Business notebook

Sale: Advent International, a Boston buyout firm with more than $2.3 billion in Latin American assets, sold Argentine generic drug maker Fada Pharma SA to Polygon Labs for an undisclosed amount.

Discontinued: Boston-based CombinatoRx discontinued development of CRx-140 as an oral treatment for psoriasis, after results of a phase 2 trial were ''not supportive."

Acquisition: TreeHouse Foods is acquiring Deerfield-based Oxford Foods for an undisclosed amount. Oxford is a producer of pickles, peppers, and related products for the food service industry.

Expansion: Genzyme chief executive Henri Termeer said his company plans to expand in Asia, with particular focus on China. The Cambridge biotech is laying the foundation of a long-term move into China.

Progress: US Trade Representative Rob Portman and EU Trade Commissioner Peter Mandelson said they made progress on how to reduce barriers to global trade in farm goods.

Bankruptcies: A new law making it harder to erase debts in bankruptcy has failed to stop abuses and has stymied people who have legitimate reasons to file, according to a report by the National Association of Consumer Bankruptcy Attorneys. Based on an analysis of 61,335 people who have gone to credit counseling agencies, the required first step before filing under a law that took effect Oct. 17, 97 percent were unable to repay any debt and 79 percent were in financial trouble because of job loss, huge medical expenses, or the death of a spouse, the report said.

Generic: The Food and Drug Administration approved the first generic version of the allergy drug Flonase, fluticasone propionate nasal spray.

Standing firm: Federal regulators will stick by their decision to slap CBS with a $550,000 fine for the Janet Jackson flash at the 2004 Super Bowl. They also plan sanctions against Fox, NBC, and CBS TV stations or affiliates for violating decency standards, according to people familiar with the matter who declined to be identified.

(Globe wire services)